Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Diffuse Intrinsic Pontine GliomaMedulloblastoma, Childhood, Recurrent

Interventions

BIOLOGICAL

AloCELYVIR

Mesenchymal allogenic cells + ICOVIR-5: 500.000 cells/kg

Trial Locations (1)

Hospital Infantil Universitario Niño Jesús, Madrid

All Listed Sponsors

collaborator

Apices Soluciones S.L.

INDUSTRY

lead

Hospital Infantil Universitario Niño Jesús, Madrid, Spain

OTHER